Bricanyl Injection, 0.5 mg/ml, solution for injection or infusion
Last Updated on eMC 27-Apr-2017 View document | AstraZeneca UK Limited Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 27-Apr-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - driving and using machines
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 28-May-2015 and displayed until 27-Apr-2017
Reasons for adding or updating:
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 06-Mar-2014 and displayed until 28-May-2015
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - use in children/adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Change to section 1 - what the product is used for
Updated on 19-Nov-2013 and displayed until 06-Mar-2014
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 24-Dec-2010 and displayed until 19-Nov-2013
Reasons for adding or updating:
- Change of manufacturer
Updated on 08-Apr-2009 and displayed until 24-Dec-2010
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 21-Oct-2008 and displayed until 08-Apr-2009
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 26-Jul-2004 and displayed until 21-Oct-2008
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 04-Sep-2002 and displayed until 26-Jul-2004
Reasons for adding or updating:
- Update to PIL
Updated on 14-Sep-2000 and displayed until 04-Sep-2002
Reasons for adding or updating:
- No reasons supplied
AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
+44 (0)1582 838 000
+44 (0)1582 838 003
+44 (0)1582 836 000
0800 783 0033
+44 (0)1582 837 837
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue